News
News-Medical.Net on MSN3d
Shift Bioscience identifies novel single-gene target for safer cellular rejuvenation therapeuticsShift Bioscience (Shift), a biotechnology company uncovering the biology of cell rejuvenation to develop new therapies for ...
NEW YORK, April 10, 2025 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading biotechnology company developing cutting-edge cell therapies for neurodegenerative diseases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback